SCHEMBL20737876

SCHEMBL20737876

CC(C)(C)c1ccc(N(c2ccc(C(C)(C)C)cc2)c2ccc3c4c(ccc3c2)-c2ccc3ccccc3c2C42c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 2/20 0.34
▸ NR1I2 O75469 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ ADRA2A P08913 1/20 0.34
▸ ACHE P22303 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ HTR2A P28223 1/20 0.34
▸ SLC6A4 P31645 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34
▸ GPR84 Q9NQS5 1/20 0.32
▸ PDK2 Q15119 1/20 0.31
▸ ALDH1A1 P00352 4/20 0.31
▸ HSD17B10 Q99714 3/20 0.31
▸ CYP1A2 P05177 2/20 0.31
▸ HPGD P15428 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ PLA2G1B P04054 1/20 0.31
▸ NFKB1 P19838 1/20 0.31
▸ CASP3 P42574 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27251255 1.00 CYP2D6 (0.34) CYP2D6NR1I2LMNAADRA2AACHE
SCHEMBL20737820 0.98 NR1I2 (0.33) CYP2D6NR1I2LMNAADRA2AACHE
SCHEMBL20736277 0.96 PDK2 (0.33) PDK2ALDH1A1NPC1PLA2G1BNFKB1
SCHEMBL20737579 0.94 PDK2 (0.34) GPR84PDK2ALDH1A1NPC1PLA2G1B
SCHEMBL20737443 0.93 LMNA (0.31) CYP2D6NR1I2LMNAADRA2AACHE
SCHEMBL20737013 0.93 GPR84 (0.33) CYP2D6NR1I2LMNAADRA2AACHE
SCHEMBL20736314 0.91 GPR84 (0.34) CYP2D6NR1I2LMNAADRA2AACHE
SCHEMBL20737805 0.91 NR1I2 (0.34) CYP2D6NR1I2LMNAADRA2AACHE
SCHEMBL20736361 0.91 NR1I2 (0.34) CYP2D6NR1I2LMNAADRA2AACHE
SCHEMBL20737336 0.90 PDK2 (0.32) CYP2D6NR1I2LMNAADRA2AACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 — — US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 — — US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 CYP2D6 1828/4885NR1I2 1371/4885LMNA 1778/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 CYP2D6 1828/4885NR1I2 1371/4885LMNA 1778/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 CYP2D6 1828/4885NR1I2 1371/4885LMNA 1778/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback